QUETTA: Heavy rains, thunderstorms, and hailstones continued to lash various districts of Balochistan, including its capital, on Saturday
SOUTH KOREA: South Korean drugmaker Celltrion Inc has announced positive results for its experimental antibody Covid-19 treatment that it said was safe and reduced the treatment period by nearly five days in Phase 3 global clinical trials.
The trials, which involved 1,315 participants, have taken place since January in 13 countries, including in South Korea, the United States, Spain and Romania, Celltrion said in a statement.
The treatment slowed severe symptoms of Covid-19 in more than 70 per cent of patients, including the high risk group with underlying conditions. It also cut the recovery period by 4.9 days, the company said.
You May Also Like
GAZA: Hamas has said it was studying Israel’s latest counterproposal for a Gaza ceasefire, a day after media reports said a delegation
ISLAMABAD: Prime Minister Shehbaz Sharif has ordered an increase in the wheat procurement target from 1.4 million tonnes to